title: The role of prenatal steroids at 34-36 weeks of gestation.
authors.affiliation: Department of Obstetrics and Gynaecology, Cambridge University, Cambridge, UK.
authors.forename: Gordon Cs
authors.initials: GC
authors.lastname: Smith
authors.affiliation: Department of Paediatrics, Wellcome Trust-MRC Stem Cell Institute, University of Cambridge, Cambridge, UK.
authors.forename: David
authors.initials: D
authors.lastname: Rowitch
authors.affiliation: Department of Obstetrics and Gynaecology, The Robinson Research Institute, School of Medicine, University of Adelaide, Adelaide, Australia.
authors.forename: Ben Wj
authors.initials: BW
authors.lastname: Mol
mesh_terms: D019317:Evidence-Based Medicine / Q000379:methods; D005260:Female; D005865:Gestational Age; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D011247:Pregnancy; D047928:Premature Birth / Q000188:drug therapy; D011297:Prenatal Exposure Delayed Effects
chemical_list: D005938:Glucocorticoids
keywords: Evidence Based Medicine; Fetal Medicine